Research ArticleArticle
Tumor Necrosis Factor–α Promoter -308/238 Polymorphism Association with Less Severe Disease in Ankylosing Spondylitis is Unrelated to Serum TNF-α and Does Not Predict TNF Inhibitor Response
Johannes C. Nossent, Sylvia Sagen-Johnsen and Gunnstein Bakland
The Journal of Rheumatology July 2014, jrheum.131315; DOI: https://doi.org/10.3899/jrheum.131315
Johannes C. Nossent
From the Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway. Supported by an investigator grant from Abbott Norway AS (grantnr. IMM 09-0054). J.C. Nossent, MD, PhD, Professor of Medicine; S. Sagen-Johnsen, PhD, bioengineer; G. Bakland, MD, PhD, Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø. Dr. J.C. Nossent is currently at Sir Charles Gairdner Hospital, Perth, Australia. Dr. S. Sagen-Johnsen is currently at University in Aas, Norway. Dr. G. Bakland is at University Hospital North Norway, Tromsø. Address correspondence to Dr. J.C. Nossent, School of Medicine, University of Western Australia, M503, Harry Perkins Institute for Medical Research, 2nd Floor, QQ Block, Room 226, QEII Medical Centre, 6 Verdun St., Nedlands, Western Australia 6009. E-mail: hans.nossent@uit.no. Accepted for publication March 24, 2014.
Sylvia Sagen-Johnsen
From the Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway. Supported by an investigator grant from Abbott Norway AS (grantnr. IMM 09-0054). J.C. Nossent, MD, PhD, Professor of Medicine; S. Sagen-Johnsen, PhD, bioengineer; G. Bakland, MD, PhD, Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø. Dr. J.C. Nossent is currently at Sir Charles Gairdner Hospital, Perth, Australia. Dr. S. Sagen-Johnsen is currently at University in Aas, Norway. Dr. G. Bakland is at University Hospital North Norway, Tromsø. Address correspondence to Dr. J.C. Nossent, School of Medicine, University of Western Australia, M503, Harry Perkins Institute for Medical Research, 2nd Floor, QQ Block, Room 226, QEII Medical Centre, 6 Verdun St., Nedlands, Western Australia 6009. E-mail: hans.nossent@uit.no. Accepted for publication March 24, 2014.
Gunnstein Bakland
From the Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway. Supported by an investigator grant from Abbott Norway AS (grantnr. IMM 09-0054). J.C. Nossent, MD, PhD, Professor of Medicine; S. Sagen-Johnsen, PhD, bioengineer; G. Bakland, MD, PhD, Bone and Joint Research Group, Department of Clinical Medicine, University of Tromsø. Dr. J.C. Nossent is currently at Sir Charles Gairdner Hospital, Perth, Australia. Dr. S. Sagen-Johnsen is currently at University in Aas, Norway. Dr. G. Bakland is at University Hospital North Norway, Tromsø. Address correspondence to Dr. J.C. Nossent, School of Medicine, University of Western Australia, M503, Harry Perkins Institute for Medical Research, 2nd Floor, QQ Block, Room 226, QEII Medical Centre, 6 Verdun St., Nedlands, Western Australia 6009. E-mail: hans.nossent@uit.no. Accepted for publication March 24, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Tumor Necrosis Factor–α Promoter -308/238 Polymorphism Association with Less Severe Disease in Ankylosing Spondylitis is Unrelated to Serum TNF-α and Does Not Predict TNF Inhibitor Response
Johannes C. Nossent, Sylvia Sagen-Johnsen, Gunnstein Bakland
The Journal of Rheumatology Jul 2014, jrheum.131315; DOI: 10.3899/jrheum.131315
Tumor Necrosis Factor–α Promoter -308/238 Polymorphism Association with Less Severe Disease in Ankylosing Spondylitis is Unrelated to Serum TNF-α and Does Not Predict TNF Inhibitor Response
Johannes C. Nossent, Sylvia Sagen-Johnsen, Gunnstein Bakland
The Journal of Rheumatology Jul 2014, jrheum.131315; DOI: 10.3899/jrheum.131315